PROCYON CORPORATION

PCYN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $1.4M $1.2M $1.2M $1.2M $1.2M $1.1M $1.2M $1.2M
Cost of Revenue $308.2K $260.8K $263.3K $260.7K $265.2K $263.6K $293.5K $294.9K
Gross Profit $1.1M $937.8K $936.7K $912.4K $937.0K $861.3K $890.5K $880.8K
Gross Margin 78.2% 78.2% 78.1% 77.8% 77.9% 76.6% 75.2% 74.9%
Operating Expenses
Research & Development
SG&A Expense $507.3K $503.2K $535.7K $491.8K $461.8K $446.7K $474.4K $424.1K
Operating Income $8.9K $-81.8K $-101.4K $-57.4K $-3.2K $-51.2K $-31.5K $-11.5K
Operating Margin 0.6% -6.8% -8.5% -4.9% -0.3% -4.6% -2.7% -1.0%
Interest Expense $0 $0 $0 $0 $0
Pretax Income $25.2K $-65.9K $-87.4K $-43.2K $10.5K $-38.8K $-26.5K $-10.6K
Income Tax Expense $-12.7K $36.9K $155.0K $-9.4K $3.0K $-9.4K $-6.4K $-2.4K
Net Income $38.0K $-102.8K $-242.5K $-33.9K $7.5K $-29.5K $-20.1K $-8.2K
Net Margin 2.7% -8.6% -20.2% -2.9% 0.6% -2.6% -1.7% -0.7%
EPS (Basic) $0.01 $-0.01 $-0.03 $-0.01 $-0.01 $0.00 $0.00 $0.00
EPS (Diluted) $0.01 $-0.01 $-0.03 $-0.01 $-0.01 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M
Shares Outstanding (Diluted) 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M
Dividends Per Share
← Newer Page 1 of 7 Older →